Your browser doesn't support javascript.
loading
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.
Vigón, Lorena; Fuertes, Daniel; García-Pérez, Javier; Torres, Montserrat; Rodríguez-Mora, Sara; Mateos, Elena; Corona, Magdalena; Saez-Marín, Adolfo J; Malo, Rosa; Navarro, Cristina; Murciano-Antón, María Aranzazu; Cervero, Miguel; Alcamí, José; García-Gutiérrez, Valentín; Planelles, Vicente; López-Huertas, María Rosa; Coiras, Mayte.
Afiliação
  • Vigón L; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Fuertes D; School of Telecommunications Engineering, Universidad Politécnica de Madrid, Madrid, Spain.
  • García-Pérez J; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Torres M; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Rodríguez-Mora S; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Mateos E; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Corona M; Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Saez-Marín AJ; Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Malo R; Neumology Service, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
  • Navarro C; Neumology Service, Hospital de El Escorial, El Escorial, Spain.
  • Murciano-Antón MA; Family Medicine, Centro de Salud Doctor Pedro Laín Entralgo, Alcorcón, Spain.
  • Cervero M; Internal Medicine Service, Hospital Universitario Severo Ochoa, Leganés, Spain.
  • Alcamí J; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • García-Gutiérrez V; Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Planelles V; Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, UT, United States.
  • López-Huertas MR; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Coiras M; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Front Immunol ; 12: 665329, 2021.
Article em En | MEDLINE | ID: mdl-34122423

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Admissão do Paciente / Leucócitos Mononucleares / Citotoxicidade Imunológica / SARS-CoV-2 / COVID-19 / Unidades de Terapia Intensiva Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Admissão do Paciente / Leucócitos Mononucleares / Citotoxicidade Imunológica / SARS-CoV-2 / COVID-19 / Unidades de Terapia Intensiva Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha País de publicação: Suíça